RBP7 and malignant colon neoplasm: Additionally, we found that also on the mRNA level, RBP7 was significantly linked with poor outcome in an independent collection of 457 colon cancers from TCGA that included all tumor stages, and also was an independent prognostic biomarker in this case collection.